SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Swami Vivekananda — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientVivekananda
Date of birth1863-01-12
IdentifiersMRN HR-NI032-SYN-TD; SSN (made up) 000-32-9014
Document date1898-02-16
AuthorAnjali Thornbury-Mensah, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Diagnosis visit: fasting test results with the endocrinology consultation. [S]

History of Present Illness

Swami Vivekananda returns one week after his first visit, fasting since the evening meal, for blood tests drawn this morning and his consultation with Dr. Lindqvist-Bose. He is still thirsty and passes urine three times a night. He has drunk water freely as advised. A few days ago he kept the night-long fast of a major festival, without water until the next morning, and felt light-headed and very thirsty by dawn; he asked how he can keep his fasts safely. His home blood pressure readings over the week averaged 136/86. He wants to know what kind of diabetes this is and whether he will need injections. [S]

ElementDetail
SymptomsThirst; nocturia three times; tiredness; weight 72.8 kg
FastingA night-long waterless festival fast a few days ago, with light-headedness by dawn
Home blood pressureAverage 136/86 over seven days
His questionsWhat kind of diabetes, whether injections are needed, and how to keep his fasts

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired; weight down a further 0.2 kg
GenitourinaryPositiveFrequent urination, three times a night
EyesPositiveReading vision blurred at times
GastrointestinalNegativeNo abdominal pain, nausea or vomiting
NeurologicalNegativeNo numbness or tingling

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin extended-release 500 mg tablets: two tablets (1000 mg) with the evening meal, starting with one for the first week1000 mg with the evening mealOral route1898-02-16 to 1898-03-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1898-02-16Body height172cmS
1898-02-16Body weight72.8kgS
1898-02-16Body mass index (BMI) [Ratio]24.6kg/m2S
1898-02-16Systolic blood pressure136mm[Hg]S
1898-02-16Diastolic blood pressure86mm[Hg]S
1898-02-16Heart rate80/minS
1898-02-16Respiratory rate16/minS
1898-02-16Body temperature36.7CelS
1898-02-16Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1898-02-16Hemoglobin A1c/Hemoglobin.total in Blood9.4%Below 5.7% is normal; 6.5% or more diabetes; his target below 7%HighS
1898-02-16Glucose [Mass/volume] in Serum or Plasma172mg/dLFasting; 126 mg/dL or more indicates diabetesHighS
1898-02-16Glutamate decarboxylase 65 Ab [Units/volume] in Serum by Immunoassay1.2[IU]/mLBelow 5 IU/mL negativeNormalS
1898-02-16C peptide [Mass/volume] in Serum or Plasma2.6ng/mL0.8-3.5 ng/mLNormalS
1898-02-16Albumin/Creatinine [Mass Ratio] in Urine46mg/g30 to 299 moderately increased; 300 or more severely increasedHighS
1898-02-16Cholesterol [Mass/volume] in Serum or Plasma214mg/dL<=199 mg/dLHighS
1898-02-16Cholesterol in HDL [Mass/volume] in Serum or Plasma36mg/dL40 mg/dL or more for menLowS
1898-02-16Triglyceride [Mass/volume] in Serum or Plasma228mg/dL<=149 mg/dLHighS
1898-02-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation132mg/dL<=99 mg/dLHighS
1898-02-16Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-55 U/LNormalS
1898-02-16Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4 mIU/LNormalS
1898-02-16Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma312pg/mL232-1245 pg/mLNormalS

Physical Exam

Vital signs recorded on 1898-02-16; see the Vital Signs section. [S]

SystemFinding
GeneralWell, alert and forthright; weight 72.8 kg, BMI 24.6; blood pressure 136/86, pulse 80
SkinNo acanthosis nigricans; mucous membranes moist
FeetSkin intact; pulses present; monofilament and vibration sense normal
CardiovascularRegular rhythm; no edema

Problems

ProblemClinical statusVerificationCodeProvenance
Thirst, frequent urination day and night, tiredness and about 4 kg weight loss over two months, with a random glucose of 246 mg/dL; told by physicians a year ago that he had diabetes, never confirmed with modern tests or treated except by diet. Diabetes to be confirmed and classified (type 2, type 1 or slowly progressive autoimmune diabetes) with A1c, fasting glucose, GAD antibodies and C-peptideresolvedconfirmed R73.9S — Synthetic presenting problem anchored to his documented diabetes of the year before. Superseded by the diagnosis at the second visit.
Type 2 diabetes: A1c 9.4 percent and fasting glucose 172 mg/dL, with symptoms; GAD65 antibodies negative and fasting C-peptide preserved (2.6 ng/mL); no ketones. BMI 24.6, in the range where ADA screens Asian Americans. Classified as type 2, not type 1 or slowly progressive autoimmune diabetesactiveconfirmed E11.65S — Synthetic modern confirmation and classification linked to his documented diabetes.
Moderately increased albuminuria on a first sample (urine albumin-to-creatinine ratio 46 mg/g), eGFR normal; to be confirmed on two of three samples over three to six monthsactiveconfirmed R80.9S — Synthetic finding linked to his documented albuminuria; superseded when diabetic kidney disease was confirmed.
Raised blood pressure in clinic (138/86, average of two readings) without a diagnosis of hypertension; home readings to be takenactiveconfirmed R03.0S — Synthetic finding; not a claim about his real blood pressure.
Long-standing difficulty falling asleep: by his own account he has never been able to fall asleep on getting into bed and lies awake for two hours or more most nights; worse lately with waking to pass urine; rises before dawn for meditationactiveconfirmed G47.00S — Synthetic modern problem linked to his documented lifelong difficulty falling asleep.
Mixed hyperlipidemia: LDL cholesterol 132 mg/dL, triglycerides 228, HDL 36activeconfirmed E78.2S — Synthetic cardiovascular risk factor.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryA1c and fasting glucoseAt diagnosis; quarterly until at goalCompleted todayA1c 9.4 percent; fasting glucose 172 mg/dL
LaboratoryClassification: GAD65 antibodies and C-peptideAt diagnosis when type 1 or autoimmune diabetes is possible (young, lean or weight loss)Completed todayGAD65 antibodies 1.2 IU/mL (negative); C-peptide 2.6 ng/mL (preserved); urine ketones negative last week
LaboratoryUrine albumin-to-creatinine ratio and eGFRAt diagnosis, then yearly; two of three abnormal over three to six months to confirmCompleted today46 mg/g, moderately increased; eGFR 106 last week
LaboratoryLipid panelAt diagnosisCompleted todayLDL 132, triglycerides 228, HDL 36
LaboratoryALT with FIB-4 (fatty liver screen) and TSHAt diagnosisCompleted todayALT 38; FIB-4 0.6 (low risk); TSH 1.8
LaboratoryVitamin B12Periodically on long-term metformin; baseline because he eats mostly vegetarian foodCompleted today312 pg/mL, normal
ExaminationBlood pressure, weight and BMIEvery visitCompleted today136/86; home 136/86; weight 72.8 kg, BMI 24.6
ExaminationComprehensive foot examinationAt diagnosis, then yearlyCompleted todayNormal monofilament and vibration; pulses present
ReferralDilated eye examination or retinal photographsAt diagnosis, then every one to two yearsOrderedRetinal photographs booked for the next visit
Self-managementDiabetes self-management education and medical nutrition therapyAt diagnosisReferredDietitian this week: a mostly vegetarian plan built on his monastery meals
Self-managementFasting risk assessment and planBefore any religious fastCompleted todayModerate risk; plan for fruit-and-milk fasts; no waterless fasts until glucose is steady
Medication safetyHypoglycemia reviewEvery visit on insulin or a sulfonylureaNot indicatedNeither used; sulfonylureas avoided because of his fasting
Self-managementTobacco useEvery visitCompleted todayNone now
SurveyDepression, anxiety and diabetes distressAt diagnosis and yearlyUp to datePHQ-2 0 last week; full screens at the preventive visit
Self-managementVaccinationsYearlyCompleted todayInfluenza, COVID-19 and PCV20 today; hepatitis B and Tdap at the preventive visit

Goal progress:

Immunizations given today: Influenza vaccine, this season; COVID-19 mRNA vaccine, this season's formula; Pneumococcal conjugate vaccine PCV20 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension, hyperlipidemia, CKD and asthma monographs (2026); 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026 (2026); 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026 (2026); 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026 (2026); Gujral UP, et al. Type 2 diabetes in South Asians: similarities and differences with white Caucasian and other populations. Ann N Y Acad Sci 2013;1281:51-63 (PMID 23317344) (2013); Hassanein M, et al. Diabetes and Ramadan: Practical guidelines 2021. Diabetes Res Clin Pract 2022;185:109185 (PMID 35016991) (2021)

Follow-up: Preventive visit in three weeks. Diabetes review in five weeks, with retinal photographs and the repeat urine albumin. Call for vomiting, abdominal pain, drowsiness or glucose above 300 mg/dL. Next scheduled visit 1898-03-09: periodic preventive visit. [S]